Daniel Rosenbaum

Endocrinology in Willingboro, New Jersey

Practice Details

Address
218C Sunset Rd
Willingboro, NJ 08046
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2005
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
May 2019

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 3 Endocrinology, Diabetes & Metabolism practices in Willingboro carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Daniel Rosenbaum's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 609-877-0400.

GLP-1 access in Willingboro, New Jersey

Adult obesity rate
28.7%
#42 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$224/mo
Typical New Jersey telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Jersey Medicaid, obesity indication

About 28.7% of New Jersey adults have obesity (BMI 30+), ranking the state #42 of 50 (CDC BRFSS). Our directory currently lists 6 GLP-1-relevant clinics in Willingboro. If a cash-pay route makes more sense, compounded semaglutide through New Jersey telehealth averages about $224/mo — well below brand-name Wegovy or Zepbound.

Explore more New Jersey options on the best New Jersey GLP-1 providers page, browse every Willingboro listing in the Willingboro clinic directory, or read the New Jersey Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Willingboro

Other Willingboro listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Jersey addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Jersey telehealth partners:

Featured Partners · Willingboro

Featured GLP-1 providers serving Willingboro

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Willingboro options on the Willingboro clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Willingboro obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Daniel Rosenbaum's specialty taxonomy but not the specific medications it prescribes or its current service menu. Daniel Rosenbaum is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 609-877-0400 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Daniel Rosenbaum's primary specialty on file is Endocrinology.
Daniel Rosenbaum is located at 218C Sunset Rd, Willingboro, NJ 08046. The phone number listed in the registry is 609-877-0400. Its full record is public in the CMS National Provider registry under NPI 1073515706.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Daniel Rosenbaum is currently accepting new patients. Call the practice at 609-877-0400 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.